What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a sequence within the gastric mucosal protection protein BPC, isolated from human gastric juice. It has been the subject of more than 150 peer-reviewed preclinical publications over three decades, primarily studying its effects on tissue repair across multiple organ systems.
It is not an approved drug, dietary supplement, or therapeutic product in Australia or any other country. It is sold exclusively as a research chemical for in vitro and animal research by qualified investigators.
Legal Status in Australia
As of April 2026, BPC-157 is not scheduled under the TGA Standard for Uniform Scheduling of Medicines and Poisons (SUSMP). It does not appear in Schedule 4 (Prescription Only), Schedule 8 (Controlled Drug), or other restrictive schedules.
What this means: BPC-157 is not a controlled substance in Australia. Possession and importation for research purposes is not prohibited under the Poisons Standard.
Important limitations:
- BPC-157 cannot be sold as a therapeutic product, medicine, or dietary supplement for human use without TGA ARTG registration (which it does not have)
- BPC-157 is prohibited in sport under WADA S2 (peptide hormones, growth factors, related substances) — enforced in Australia by Sport Integrity Australia
- State/territory health legislation may impose additional requirements — researchers should verify their local regulatory environment
This information is current as of April 2026 but can change. Researchers should verify current TGA scheduling via the TGA's online SUSMP tool before ordering.
Research Use Framework
Australian researchers can legitimately obtain BPC-157 for:
- In vitro studies: Cell culture, receptor binding assays, mechanistic biology
- Animal studies: Rodent models with appropriate institutional ethics approval (AEEC/AEC)
- Laboratory analysis: Reference standard material for analytical chemistry
University and institutional researchers operating under Animal Ethics Committee (AEC) approval can import research chemicals for approved protocols. Individual researchers should work through their institution's research office for guidance on importing research chemicals.
Rainbow Peptide supplies exclusively to researchers and institutions affirming legitimate research use. Our products are not supplied for human consumption.
Purity Standards for Research
Peptide purity is critical for research validity. Low-purity peptides introduce unknown contaminants that can confound experimental results. For research use, the minimum acceptable standard is:
- ≥98% HPLC purity: Measured by reverse-phase HPLC (UV detection at 214 nm)
- Mass spectrometry confirmation: Verifies the molecular weight matches the expected sequence — catches synthesis errors, deletions, or substitutions
- Third-party CoA: Certificate of analysis from an independent lab, not just the manufacturer's own testing
- Endotoxin testing: For in vivo research, LAL (limulus amebocyte lysate) endotoxin testing is important to ensure bacterial contamination is below research-relevant thresholds
Rainbow Peptide BPC-157 meets all of these standards. CoA is available for every batch and can be requested at time of order.
Shipping to Australia
Rainbow Peptide ships to Australia :
- Typical delivery: 7–14 business days from dispatch
- Customs documentation: Products declared as "research chemicals / scientific research materials" — accurate and compliant customs documentation provided
- Packaging: Lyophilized powder in sealed glass vials, shipped cold-chain where required; insulated packaging for temperature-sensitive orders
- Tracking: Full courier tracking provided at dispatch
- Minimum order: No minimum — single vials available
For more information on ordering from Australia, see our Australia peptide research page.
BPC-157 Research Overview
For researchers new to BPC-157, the key research areas documented in the preclinical literature include:
- Gastrointestinal: Gastric ulcer healing, intestinal anastomosis, IBD models (30+ publications)
- Musculoskeletal: Achilles tendon, rotator cuff, ligament, and muscle crush injury healing (20+ publications)
- Neurological: Spinal cord injury, peripheral nerve crush, CNS dopamine system studies (15+ publications)
- Wound healing: Full-thickness skin wounds, burn models, corneal injury (10+ publications)
For a full research overview, see our BPC-157 Research Guide and BPC-157 Dosage Protocols Guide.